NCT07040917View on ClinicalTrials.gov

A Study of CAR-T Cells in Subjects With Autoimmune Diseases

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

April 30, 2028

Conditions

Autoimmune Diseases

Interventions

DRUG

CAR-T cell

CAR-T cell

Trial Locations (1)

100000

Chinese PLA General Hospital, Beijing

All Listed Sponsors

lead

Chinese PLA General Hospital

OTHER